© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
January 13, 2021
AstraZeneca’s leading diabetes medication could be approved to treat chronic kidney disease for patients with and without type 2 diabetes.
June 02, 2020
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
September 24, 2019
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
July 22, 2019
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
July 08, 2019
FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
April 02, 2019
FDA fast-tracks biosimiliar insulin products to elevate competition.
March 06, 2019
February 19, 2019
FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.
June 25, 2018
July 29, 2016
Mayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.